glutamic acid has been researched along with Muscular Weakness in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (87.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarke, NF; Domazetovska, A; Kornberg, A; McLean, C; North, KN; Waddell, L | 1 |
Batish, SD; Biesecker, LG; Blouin, R; Brandt, C; Coppola, G; Ferguson, CJ; Grant, AE; Hoffman, S; Lenk, GM; Meisler, MH; Nicholson, G; Reddel, SW; Scheuerle, A; Simpson, E; Towne, CF; Yasick, M | 1 |
Cheema, SS; McQuilty, R; Pamphlett, R; Todd, E; Vink, R | 1 |
Schröder, JM; Sindern, E; Vorgerd, M; Züchner, S | 1 |
Förster, H; Huemer, M; Idriceanu, C; Kamper, A; Mayr, JA; Moslemi, AR; Muss, W; Oldfors, A; Sperl, W | 1 |
Benarroch, EE | 1 |
Bensimon, G; Dib, M; Lacomblez, L; Le Forestier, N; Marouan, A; Meininger, V; Pradat, PF; Salachas, F; Spreux-Varoquaux, O | 1 |
Alexander, GM; Deitch, JS; Del Valle, L; Heiman-Patterson, TD | 1 |
1 review(s) available for glutamic acid and Muscular Weakness
Article | Year |
---|---|
Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy.
Topics: Apnea; Brain Stem; Catecholamines; Glutamic Acid; Humans; Multiple System Atrophy; Muscle Weakness; Muscle, Skeletal; Neurons; Periodicity; Pons; Receptors, Neurokinin-1; Respiratory Insufficiency; Respiratory Physiological Phenomena; Respiratory Sounds; Serotonin; Solitary Nucleus | 2007 |
7 other study(ies) available for glutamic acid and Muscular Weakness
Article | Year |
---|---|
Cap disease due to mutation of the beta-tropomyosin gene (TPM2).
Topics: Adolescent; Amino Acid Sequence; Base Sequence; Cardiomyopathies; DNA Mutational Analysis; Female; Genetic Markers; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Humans; Muscle Fibers, Skeletal; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Myocardium; Sarcomeres; Sequence Deletion; Tropomyosin | 2009 |
Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4.
Topics: Adult; Australia; Charcot-Marie-Tooth Disease; Child; Child, Preschool; Exons; Family Health; Female; Flavoproteins; Foot Deformities; Genotype; Glutamic Acid; Humans; Lysine; Male; Middle Aged; Models, Molecular; Muscle Weakness; Mutation; Neural Conduction; Phenotype; Phosphoric Monoester Hydrolases; Sural Nerve | 2011 |
Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS.
Topics: Age of Onset; Amyotrophic Lateral Sclerosis; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Hand Strength; Magnesium; Mice; Mice, Transgenic; Muscle Weakness; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate; Treatment Failure | 2003 |
The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Axons; Charcot-Marie-Tooth Disease; Deafness; DNA Mutational Analysis; Female; Genetic Testing; Glutamic Acid; Humans; Lysine; Male; Microscopy, Electron; Middle Aged; Muscle Weakness; Mutation; Neural Conduction; Neurofilament Proteins; Pedigree; Peripheral Nerves; Phenotype; Protein Structure, Tertiary; Sural Nerve | 2004 |
A novel sporadic mutation G14739A of the mitochondrial tRNA(Glu) in a girl with exercise intolerance.
Topics: Brain; Child; DNA Mutational Analysis; Exercise Tolerance; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Mitochondrial Diseases; Mitochondrial Myopathies; Muscle Fibers, Skeletal; Muscle Weakness; Muscle, Skeletal; Mutation; RNA; RNA, Mitochondrial; RNA, Transfer | 2006 |
Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients.
Topics: Age Factors; Aged; Amyotrophic Lateral Sclerosis; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Cohort Studies; Colorimetry; Disease Progression; Female; Glutamic Acid; Humans; Male; Middle Aged; Muscle Weakness; Neurons; Paresis; Rhombencephalon; Sex Factors; Spinal Cord | 2002 |
GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
Topics: Aging; Amino Acid Transport System X-AG; Amyotrophic Lateral Sclerosis; Animals; Carrier Proteins; Central Nervous System; Dimerization; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Female; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Immunohistochemistry; Male; Mice; Mice, Transgenic; Molecular Weight; Motor Neurons; Muscle Weakness; Mutation; Phenotype; Superoxide Dismutase; Superoxide Dismutase-1; Symporters | 2002 |